We showed that SARS-CoV-2 promotes α-synuclein mediated NLRP3 inflammasome activation by priming MDMi through spike protein, providing ex vivo support for the negative impact of SARS-CoV-2 on neurodegenerative diseases such as PD. Here, NLRP3 is linked to Parkinson disease.